Your browser doesn't support javascript.
loading
High Amounts of SARS-CoV-2 Precede Sickness Among Asymptomatic Health Care Workers.
Dillner, Joakim; Elfström, K Miriam; Blomqvist, Jonas; Engstrand, Lars; Uhlén, Mathias; Eklund, Carina; Boulund, Fredrik; Lagheden, Camilla; Hamsten, Marica; Nordqvist-Kleppe, Sara; Seifert, Maike; Hellström, Cecilia; Olofsson, Jennie; Andersson, Eni; Falk, August Jernbom; Bergström, Sofia; Hultin, Emilie; Pin, Elisa; Pimenoff, Ville N; Hassan, Sadaf; Månberg, Anna; Nilsson, Peter; Hedhammar, My; Hober, Sophia; Mattsson, Johan; Arroyo Mühr, Laila Sara; Lundgren, Kalle Conneryd.
Afiliación
  • Dillner J; Karolinska University Laboratory, Karolinska University Hospital, Stockholm, Sweden.
  • Elfström KM; Karolinska University Laboratory, Karolinska University Hospital, Stockholm, Sweden.
  • Blomqvist J; Karolinska University Hospital, Stockholm, Sweden.
  • Engstrand L; Karolinska University Laboratory, Karolinska University Hospital, Stockholm, Sweden.
  • Uhlén M; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.
  • Eklund C; Science for Life Laboratory, Stockholm, Sweden.
  • Boulund F; Science for Life Laboratory, Stockholm, Sweden.
  • Lagheden C; Karolinska University Laboratory, Karolinska University Hospital, Stockholm, Sweden.
  • Hamsten M; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.
  • Nordqvist-Kleppe S; Karolinska University Laboratory, Karolinska University Hospital, Stockholm, Sweden.
  • Seifert M; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.
  • Hellström C; Karolinska University Laboratory, Karolinska University Hospital, Stockholm, Sweden.
  • Olofsson J; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.
  • Andersson E; Division of Affinity Proteomics, Department of Protein Science, Royal Institute of Technology, Science for Life Laboratory, Stockholm, Sweden.
  • Falk AJ; Division of Affinity Proteomics, Department of Protein Science, Royal Institute of Technology, Science for Life Laboratory, Stockholm, Sweden.
  • Bergström S; Division of Affinity Proteomics, Department of Protein Science, Royal Institute of Technology, Science for Life Laboratory, Stockholm, Sweden.
  • Hultin E; Division of Affinity Proteomics, Department of Protein Science, Royal Institute of Technology, Science for Life Laboratory, Stockholm, Sweden.
  • Pin E; Division of Affinity Proteomics, Department of Protein Science, Royal Institute of Technology, Science for Life Laboratory, Stockholm, Sweden.
  • Pimenoff VN; Karolinska University Laboratory, Karolinska University Hospital, Stockholm, Sweden.
  • Hassan S; Division of Affinity Proteomics, Department of Protein Science, Royal Institute of Technology, Science for Life Laboratory, Stockholm, Sweden.
  • Månberg A; Karolinska University Laboratory, Karolinska University Hospital, Stockholm, Sweden.
  • Nilsson P; Karolinska University Laboratory, Karolinska University Hospital, Stockholm, Sweden.
  • Hedhammar M; Division of Affinity Proteomics, Department of Protein Science, Royal Institute of Technology, Science for Life Laboratory, Stockholm, Sweden.
  • Hober S; Division of Affinity Proteomics, Department of Protein Science, Royal Institute of Technology, Science for Life Laboratory, Stockholm, Sweden.
  • Mattsson J; Division of Protein Technology, Department of Protein Science, Royal Institute of Technology, AlbaNova, Stockholm, Sweden.
  • Arroyo Mühr LS; Division of Protein Technology, Department of Protein Science, Royal Institute of Technology, AlbaNova, Stockholm, Sweden.
  • Lundgren KC; Karolinska University Hospital, Stockholm, Sweden.
J Infect Dis ; 224(1): 14-20, 2021 07 02.
Article en En | MEDLINE | ID: mdl-33580261

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Personal de Salud / Enfermedades Asintomáticas / SARS-CoV-2 / COVID-19 Tipo de estudio: Diagnostic_studies / Prognostic_studies / Screening_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: J Infect Dis Año: 2021 Tipo del documento: Article País de afiliación: Suecia Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Personal de Salud / Enfermedades Asintomáticas / SARS-CoV-2 / COVID-19 Tipo de estudio: Diagnostic_studies / Prognostic_studies / Screening_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: J Infect Dis Año: 2021 Tipo del documento: Article País de afiliación: Suecia Pais de publicación: Estados Unidos